| 822 |
823: Occurrence, Cystic dilatation (renal tubule) |
820: Decreased, Renal plasma flow |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 823 |
823: Occurrence, Cystic dilatation (renal tubule) |
821: Decreased, Sodium reabsorption |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 824 |
823: Occurrence, Cystic dilatation (renal tubule) |
825: Decreased, Renal ability to dilute urine |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 855 |
836: Occurrence, Cytoplasmic vacuolization (Bile duct cell) |
838: Induction, Microvesicular fat |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 856 |
836: Occurrence, Cytoplasmic vacuolization (Bile duct cell) |
839: Formation, Mallory body |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 851 |
833: Occurrence, Cytoplasmic vacuolization (hepatocyte) |
838: Induction, Microvesicular fat |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 852 |
833: Occurrence, Cytoplasmic vacuolization (hepatocyte) |
839: Formation, Mallory body |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 857 |
837: Occurrence, Cytoplasmic vacuolization (kupffer cell) |
838: Induction, Microvesicular fat |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 858 |
837: Occurrence, Cytoplasmic vacuolization (kupffer cell) |
839: Formation, Mallory body |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 825 |
824: Occurrence, Cytoplasmic vacuolization (podocyte) |
819: Decreased, Glomerular filtration |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 826 |
824: Occurrence, Cytoplasmic vacuolization (podocyte) |
820: Decreased, Renal plasma flow |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 827 |
824: Occurrence, Cytoplasmic vacuolization (podocyte) |
821: Decreased, Sodium reabsorption |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 828 |
824: Occurrence, Cytoplasmic vacuolization (podocyte) |
825: Decreased, Renal ability to dilute urine |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 817 |
818: Occurrence, Cytoplasmic vacuolization (Renal tubule) |
819: Decreased, Glomerular filtration |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 818 |
818: Occurrence, Cytoplasmic vacuolization (Renal tubule) |
820: Decreased, Renal plasma flow |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 819 |
818: Occurrence, Cytoplasmic vacuolization (Renal tubule) |
821: Decreased, Sodium reabsorption |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 820 |
818: Occurrence, Cytoplasmic vacuolization (Renal tubule) |
825: Decreased, Renal ability to dilute urine |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1861 |
613: Occurrence, Epileptic seizure |
1350: Increased, glutamate |
Feb 13, 2019 |
Feb 13, 2019 |
None
|
| 1999 |
613: Occurrence, Epileptic seizure |
388: Overactivation, NMDARs |
Nov 13, 2019 |
Nov 13, 2019 |
None
|
| 1890 |
1623: Occurrence, Focal Seizure |
1350: Increased, glutamate |
Apr 22, 2019 |
Sep 3, 2023 |
1 AOP
|
| 1998 |
1623: Occurrence, Focal Seizure |
388: Overactivation, NMDARs |
Nov 13, 2019 |
Nov 13, 2019 |
None
|
| 989 |
921: Goblet cell hyperplasia |
943: Hypersecretion, Mucus |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1312 |
921: Goblet cell hyperplasia |
962: Increase, Mucin production |
Nov 29, 2016 |
Aug 11, 2021 |
None
|
| 2472 |
921: Goblet cell hyperplasia |
1251: Chronic, Mucus hypersecretion |
Aug 26, 2021 |
Aug 30, 2021 |
None
|
| 2648 |
814: Occurrence, Kidney toxicity |
759: Increased, Kidney Failure |
Apr 8, 2022 |
Apr 8, 2022 |
1 AOP
|